Reply to: "IFRD1: a promising target in human liver regeneration"

Taofei Zeng1, Yabin Huang1, Hao He1

  • 1Department of Hepatobiliary Surgery, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China; Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, Anhui, 230001, China; Anhui Provincial Clinical Research Center for Hepatobiliary Diseases, Hefei, Anhui, 230001, China.

Journal of Hepatology
|July 15, 2026
PubMed
Abstract

No abstract available in PubMed .